NPC: March 1, 2013
In its third annual survey of key health care stakeholders, NPC, working with the public health research firm Social & Scientific Systems (SSS), examined the environment for health care decisions, especially the current state of CER and its impact on medical decision making.
The purpose was to set a baseline for where key stakeholders believe we are today on CER and for tracking progress and judging future effects. According to the findings, respondents are expecting CER to have a larger impact on decision-making during the next five years, rather than in the near term.
CER Survey Highlights:
In the third survey to gauge attitudes around comparative effectiveness research (CER), the National Pharmaceutical Council was able to capture shifts in the conversation.
45 percent of survey respondents were “very familiar” with comparative effectiveness research and 39 percent of respondents were “somewhat familiar” with CER. Read more